EUCURE BIOPHARMA
Eucure Biopharma is a global biotechnology company headquartered in Beijing, China. They are committed to the discovery and development of innovative immuno-oncology targeted antibodies which mainly focus on immune checkpoints. Several products have entered the CMC stage and has applied for clinical trial in 2019. Their mission is to develop antibody treatments to improve the survival rate of tumor patients.
EUCURE BIOPHARMA
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
2016-11-01
Address:
Beijing, Beijing, China
Country:
China
Website Url:
http://www.eucure.com
Total Employee:
11+
Status:
Active
Contact:
86-10-5631-5309
Total Funding:
250 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Nginx Euro Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Vor Biopharma
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.
Current Employees Featured
Jian Ni Co-Founder and President @ Eucure Biopharma
Co-Founder and President
Zhihong Li VP and Chief Regulatory Affairs Officer @ Eucure Biopharma
VP and Chief Regulatory Affairs Officer
Yuelei Shen Co-Founder @ Eucure Biopharma
Co-Founder
Founder
Investors List
3E Bioventures
3E Bioventures investment in Series B - Eucure Biopharma
CMB International Capital Corporation
CMB International Capital Corporation investment in Series B - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
BVCF
BVCF investment in Series A - Eucure Biopharma
SDIC Venture Capital
SDIC Venture Capital investment in Series A - Eucure Biopharma
More informations about "Eucure Biopharma"
Eucure Biopharma - Crunchbase Company Profile
Organization. Eucure Biopharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. …See details»
About Eucure - Eucure - Eucure
Eucure Biopharma is a wholly-owned subsidiary of Biocytogen committed to clinical development. Biocytogen is an international biotechnology company that develops new drugs based on innovative technology. Biocytogen is committed …See details»
Youhe Medical Technology (Beijing) Co. Ltd. - Drug pipelines, …
Eucure Biopharma, a subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd., is a biotechnology company headquartered in Beijing, China. Specializing in the discovery and …See details»
Eucure Biopharma - Overview, News & Similar companies
Feb 27, 2023 Biocytogen/Eucure Biopharma to Present Complete Clinical Data from YH003 (anti-CD40 mAb) Phase I Trial at ESMO 2023 BEIJING--(BUSINESS WIRE)--Eucure …See details»
Eucure Biopharma - Headquarter Location, Corporate Office …
Eucure Biopharma is Drug Discovery in China that focus on developer business. Founded in 2016. They cover business area such as developer, antibody pharmaceutical, tumor, patient, …See details»
Eucure Biopharma Company Profile - Office Locations ... - Craft
Eucure Biopharma $78.96 m in total funding,. See insights on Eucure Biopharma including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Eucure - Eucure
Eucure Biopharma owns a seasoned team with in-depth experience in global clinical development, and is dedicated to providing a comprehensive range of professional services, …See details»
Eucure Biopharma - VentureRadar
Youhe Pharmaceutical is an innovative biotechnology company rooted in China with a global perspective, focusing on the development of innovative... ... Find out more ...See details»
祐和医药科技（北京）有限公司_祐和医药
祐和医药科技(北京)有限公司(简称“祐和医药”)是一家成立于2016年11月位于北京经济技术开发区、致力于创新抗体药物研发的 ...See details»
Youhe Medical Technology (Beijing) Co. Ltd. - synapse.zhihuiya.com
了解Youhe Medical Technology (Beijing) Co. Ltd. (祐和医药科技（北京）有限公司)公司的药物管线，治疗领域，技术平台，以及它的22项临床试验, 1篇新闻和3篇文献，疾病领域:肿瘤，血液 …See details»
Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, …
Oct 18, 2022 Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that the …See details»
Congratulations on Eucure Biopharma's New Site for a …
The opening ceremony of the Shanghai office of Eucure Biopharma was successfully closed, building a solid fortress for the development of Eucure Biopharma. Although the world is …See details»
Syncromune Inc Enters Into An Exclusive Worldwide License …
Oct 19, 2024 Syncromune, Inc., A Clinical Stage Biopharmaceutical Company Focused On The Development Of Combination Intratumoral Immunotherapy Announced Today That The …See details»
Syncromune, Inc. Enters into an Exclusive Worldwide License
Oct 18, 2022 FORT LAUDERDALE, Fla. & BEIJING--(BUSINESS WIRE)-- Syncromune, Inc., a clinical stage biopharmaceutical company focused on the development of combination …See details»
Eucure Biopharma Announces Partnership with ISU ABXIS for the ...
Eucure Biopharma Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence “Biocytogen utilized its unique evidence-based in …See details»
Biocytogen/Eucure Biopharma Announce the Completion of First …
The study marks the first phase II clinical trial for Biocytogen. Dr. Yuelei Shen, Chairman and CEO of Biocytogen and Eucure Biopharma, said that the company will continue making rapid …See details»
Eucure-healthcareprivatelimited | Vakilsearch
Check find out Eucure-healthcareprivatelimited's registration details online. Get an overview of the company's financials and industry details. Follow us for more updates! Consult an Expert. Talk …See details»
百奥赛图全资子公司祐和医药与美国Syncromune公司就OX40单抗 …
中国北京与美国罗德岱堡，2022年10月18日 - 百奥赛图（北京）医药科技股份有限公司（“百奥赛图”）的全资子公司祐和医药科技（北京）有限公司（“祐和医药”）今日宣布与临床阶段的美国 …See details»
祐和医药宣布其OX40获中国国家药品监督管理局批准临床 - 知乎
2020年9月2日，中国北京, 美国波士顿— 作为一家致力于开发自主知识产权肿瘤和免疫类抗体药物的生物医药公司，百奥赛图全资子公司祐和医药 (Eucure)今日宣布中国国家药品监督管理 …See details»
News - Eucure - Eucure
BEIJING, December 7, 2021 - Eucure Biopharma, a wholly owned subsidiary of Biocytogen,announced the completion of first patient dosing for phase I clinical trial of YH004 …See details»